PHINIA director receives new deferred stock unit grants
Weerasinghe Rohan reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Weerasinghe Rohan reported acquisition or exercise transactions in this Form 4 filing.
PHINIA Inc. director Rohan Weerasinghe received new equity-based compensation in the form of deferred restricted stock units (DRSUs). On May 22, 2026, he was granted 3,075 DRSUs at a reference value of $74.80 per unit and an additional 2,140 DRSUs.
Following these awards, his DRSU balance reported in this filing is 5,215 units, all tied to PHINIA common stock. Footnotes note that 8,551 DRSUs have already vested and will settle in shares when his board service ends, and that the new DRSUs were elected in lieu of his annual equity grant and cash retainer, vesting on May 22, 2027.
Insider Trade Summary
Grant/Award: 5,215 shares
Grant/Award
4 txns
Insider
Weerasinghe Rohan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Units | 2,140 | $0.00 | $0.00 |
| Grant/Award | Deferred Restricted Stock Units | 3,075 | $74.80 | $230K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Deferred Restricted Stock Units — 5,215 contracts (Direct);
Common Stock — 31,237 shares (Direct);
Common Stock — 12 shares (Indirect, By Managed Account)
Footnotes (3)
- F1. Includes 8,551 deferred restricted stock units ("DRSUs") that have vested and will settle upon the reporting person's termination of board service.
- F2. Represents DRSUs that the reporting person elected to receive in lieu of the annual non-employee director grant of shares of restricted stock. Each DRSU is the economic equivalent of one share of PHINIA Inc. common stock and will vest on May 22, 2027. These DRSUs will settle into an equal number of shares of the issuer's common stock, including any additional DRSUs acquired as a result of dividend equivalents that have vested, upon the reporting person's termination of board service pursuant to the issuer's Director Deferred Compensation Program and 2023 Stock Incentive Plan.
- F3. Represents DRSUs that the reporting person elected to receive in lieu of the annual non-employee director cash retainer. Each DRSU is the economic equivalent of one share of PHINIA Inc. common stock and will vest on May 22, 2027. These DRSUs will settle into an equal number of shares of the issuer's common stock, including any additional DRSUs acquired as a result of dividend equivalents that have vested, upon the reporting person's termination of board service pursuant to the issuer's Director Deferred Compensation Program and 2023 Stock Incentive Plan.
Key Figures
DRSUs granted (equity grant): 3,075 units
Additional DRSUs granted: 2,140 units
DRSUs following transactions: 5,215 units
+5 more
8 metrics
DRSUs granted (equity grant)
3,075 units
Deferred restricted stock units granted May 22, 2026
Additional DRSUs granted
2,140 units
Deferred restricted stock units granted May 22, 2026
DRSUs following transactions
5,215 units
Total deferred restricted stock units after grants
Reference value per DRSU
$74.80 per unit
Price per unit for 3,075 DRSU grant
Vested DRSUs
8,551 units
Vested deferred restricted stock units settling at end of board service
Direct common stock holding
31,237 shares
Common stock directly owned following reported holdings
Indirect common stock holding
12 shares
Common stock held indirectly by managed account
DRSU vesting date
May 22, 2027
Vesting date for new DRSU grants
Key Terms
Deferred Restricted Stock Units, dividend equivalents, Director Deferred Compensation Program, 2023 Stock Incentive Plan
4 terms
Deferred Restricted Stock Units financial
"Represents DRSUs that the reporting person elected to receive in lieu of the annual non-employee director grant of shares of restricted stock."
Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.
dividend equivalents financial
"including any additional DRSUs acquired as a result of dividend equivalents that have vested"
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
Director Deferred Compensation Program financial
"upon the reporting person's termination of board service pursuant to the issuer's Director Deferred Compensation Program and 2023 Stock Incentive Plan."
A director deferred compensation program is an arrangement that lets a company delay paying part of a board member’s fees or bonuses until a future date, often at retirement or after leaving the board. It matters to investors because it affects a company’s long‑term cash commitments and executive incentives—like a timed savings plan that can align directors’ decisions with the company’s future performance while creating future liabilities on the balance sheet.
2023 Stock Incentive Plan financial
"pursuant to the issuer's Director Deferred Compensation Program and 2023 Stock Incentive Plan."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PHIN (PHINIA Inc.) director Rohan Weerasinghe report on this Form 4?
He reported compensation-related equity awards, not open-market trades. On May 22, 2026, he received grants of deferred restricted stock units (DRSUs) tied to PHINIA common stock, which will vest and settle in shares according to the company’s director compensation programs.
How many deferred restricted stock units did the PHIN director acquire on May 22, 2026?
He acquired 3,075 deferred restricted stock units and an additional 2,140 DRSUs. These awards increase his reported DRSU holdings to 5,215 units, each economically equivalent to one share of PHINIA common stock under the company’s compensation and incentive plans.
What is the vesting schedule for the new PHIN deferred restricted stock units?
Both new DRSU grants vest on May 22, 2027. After vesting, they will settle into an equal number of PHINIA common shares when his board service ends, under the Director Deferred Compensation Program and the 2023 Stock Incentive Plan.
How many vested PHIN deferred restricted stock units does the director already have?
Footnotes state he has 8,551 vested DRSUs. These vested units will settle into an equal number of PHINIA common shares, including any additional DRSUs from dividend equivalents, upon his termination of board service under the company’s deferred compensation arrangements.
Are the PHIN DRSU awards open-market purchases or compensation grants?
They are compensation grants, not market purchases. The Form 4 labels the transactions with code A, indicating grants or awards, and the footnotes explain they were elected in lieu of the annual non-employee director stock grant and cash retainer.
How do PHIN deferred restricted stock units relate to PHINIA common stock?
Each DRSU is the economic equivalent of one share of PHINIA common stock. Upon settlement, the DRSUs convert into an equal number of shares, including additional units accumulated through dividend equivalents, according to the company’s director compensation programs.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates